Developer docs
API playgroundTry for free, no card

Search company profiles

CERMEP

Full company profile

uuid00446hj

Namestring
CERMEP
Legal namestring
CERMEP - Imagerie du Vivant (Centre d'Etude et de Recherche Multimodal Et Pluridisciplinaire en imagerie du vivant)
Websiteurl
cermep.fr
Company typeenum
Private
Founded yearint
2007
Descriptiontext

CERMEP — Centre d'Étude et de Recherche Multimodal Et Pluridisciplinaire en imagerie du vivant — is a French publicly funded research support unit (Unité d'appui à la Recherche) labeled by CNRS as UAR 2053, by INSERM as US65, and supported by Lyon1 Université Claude Bernard and Hospices Civils de Lyon. Headquartered at the Groupement Hospitalier Est in Bron, France, the platform provides in vivo biomedical imaging services spanning preclinical (small and medium animal) and clinical research, anchored by a multimodal equipment fleet that includes PET (with combined PET/MRI and PET/CT scanners), MRI at 1.5T, 3T, and 7T (including a 7T microMRI), spectral photon-counting CT (SPCCT), magnetoencephalography (MEG) using OPM sensors, and functional ultrasound (fUS). The platform supplements imaging with on-site radiopharmaceutical production via cyclotron and radiochemistry laboratories, pharmacokinetic modeling, image data analysis, and a preclinical animal facility with a radiosurgical block.

The business model is publicly funded rather than commercial: revenue flows from institutional grants and contributions by CNRS, INSERM, Lyon1, and Hospices Civils de Lyon, supplemented by collaborative research agreements with pharmaceutical and biotechnology industry partners. Customer segments split between academic biomedical researchers (primary, preclinical and translational), clinical research teams (RIPH 1 & 2 interventional studies, GCP-trained personnel, ISO 9001-certified processes since 2007), and industry partners (drug development imaging, pharmacokinetic characterization, biomarker validation, clinical trial support). Go-to-market is enterprise field sales in nature — protocols are designed with researchers and validated by the platform's Comex committee before any imaging study is initiated.

CERMEP additionally functions as a biomedical validation hub for next-generation imaging prototypes, with active co-development engagements with Philips (SPCCT v2), MAG4HEALTH (OPM-MEG sensors), DAMAVAN Imaging (3D Compton camera prototype), and ICONEUS (functional ultrasound). The platform's competitive position rests on the unique convergence of regulated clinical-grade quality management (ISO 9001 since 2007), capital-intensive multimodal hardware unavailable at most European research sites, and structural embedding within one of Europe's densest hospital-university complexes.

Short descriptiontext

CERMEP is a French publicly funded multimodal biomedical imaging platform in Bron, serving academic and industrial researchers with PET, MRI, MEG, spectral CT, functional ultrasound, and on-site radiopharmaceutical production for preclinical and clinical studies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBron, France
HQ citystring
Bron
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical imaging research, multimodal imaging platform, PET radiopharmaceutical production, preclinical clinical imaging, translational imaging services
Industry2 codes
PRIMARYHLAGAAAJ
Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG)
SECONDARYHLAFAKAK
Neurodiagnostic Centers (EEG/EMG/NCS)
NAICS code4 codes
  • Diagnostic Imaging Centers621512
  • Other Scientific and Technical Consulting Services54169
  • Veterinary Services54194
  • Professional, Scientific, and Technical Services54
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Biomedical Imaging Research Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Research Services (Public Funding)
TypeManaged Services
Description

CERMEP operates as a CNRS/INSERM research support unit (UAR 2053 / US65) funded by French public research institutions including CNRS, INSERM, Lyon1 Université Claude Bernard, and Hospices Civils de Lyon. Revenue derived from public research grants and institutional support.

cermep.fr
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Infrastructure, Personnel, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CERMEP is a multimodal biomedical imaging platform providing preclinical and clinical in vivo imaging services. It combines PET, MRI (1.5T, 3T, 7T, micro-IRM), combined PET-MRI, PET/CT, spectral photon-counting CT, MEG, and functional ultrasound with on-site radiopharmaceutical production via cyclotron, pharmacokinetic modeling, and image data analysis. Services are delivered to academic researchers and industrial partners through validated protocols executed by specialized imaging teams.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CERMEP is a unified multimodal biomedical imaging platform combining preclinical and clinical imaging services within a single hospital-university site. Its core offering integrates a suite of imaging modalities — PET molecular imaging, MRI (1.5T, 3T, 7T, and micro-IRM 7T), combined PET-MRI, PET/CT, spectral photon-counting CT (SPCCT), MEG, and functional ultrasound (fUS) — with on-site radiopharmaceutical production via cyclotron, pharmacokinetic modeling, and advanced image data analysis services. The platform also provides preclinical animal housing and a radiosurgical block, and serves as a biomedical validation hub for academic and industrial imaging prototype development. Services are delivered through specialized technical teams (MER, engineers, technicians) and support the full research pipeline from protocol design through data acquisition, analysis, and methodological innovation.

Product and service15 records
1PET Molecular Imaging (Imagerie moléculaire TEP)
CategoryImaging Modality
Description

Positron emission tomography for functional imaging of radiopharmaceutical biodistribution as markers of biological processes. Available for preclinical and clinical research.

2MRI Imaging (Imagerie par Résonance Magnétique)
CategoryImaging Modality
Description

Magnetic resonance imaging at 1.5T, 3T, and 7T field strengths, covering both preclinical (micro-IRM 7T) and clinical anatomical and functional imaging.

3Combined PET-MRI (TEP-IRM combinée)
CategoryImaging Modality
Description

Combined PET-MRI scanner enabling simultaneous acquisition of molecular (PET) and anatomical/functional (MRI) data in a single imaging session for integrated research.

4PET/CT Imaging (TEP/CT)
CategoryImaging Modality
Description

Combined PET/CT scanner merging molecular PET data with anatomical CT data for clinical and preclinical imaging research.

5Spectral Photon-Counting CT (SPCCT)
CategoryImaging Modality
Description

Spectral CT scanner using photon-counting detector technology for anatomical and functional multispectral imaging.

6Magnetoencephalography (MEG)
CategoryImaging Modality
Description

Functional imaging of cerebral magnetic field changes, including next-generation optically pumped magnetometer (OPM) sensors.

7Functional Ultrasound (fUS)
CategoryImaging Modality
Description

High-resolution functional ultrasound imaging for preclinical studies utilizing ICONEUS technology.

8MicroPET/CT (MicroTEP/CT)
CategoryPreclinical Imaging
Description

Preclinical micro-PET/CT system for small animal (rodent) imaging combining molecular and anatomical imaging.

9MicroMRI 7T (MicroIRM 7T)
CategoryPreclinical Imaging
Description

7 Tesla micro-MRI scanner for high-resolution preclinical anatomical and functional imaging of small animals.

10PET Radiopharmaceutical Production (Production de radiopharmaceutiques TEP)
CategoryRadiopharmacy
Description

On-site production of PET radiopharmaceuticals using the cyclotron and radiosynthesis laboratories, including development of new radiotracers and labeling pathways.

11Pharmacokinetic Modeling (Modélisation pharmacocinétique)
CategoryAnalysis Service
Description

Pharmacokinetic modeling services using compartmental modeling with invasive input function and reference region methods, spanning preclinical animal studies through first-in-human clinical studies.

12Image Data Analysis (Analyse de données d'imagerie)
CategoryAnalysis Service
Description

Image data analysis services covering preprocessing, processing, and analysis of PET-MRI combined and MEG data, including custom tool and script development.

13Animal Facility and Preclinical Experimentation (Animalerie / Expérimentation animale)
CategoryPreclinical Service
Description

Preclinical animal experimentation and housing facilities for imaging studies across species including rodents, rabbits, pigs, and non-human primates.

14Radiosurgical Operating Block (Bloc radiochirurgical)
CategoryPreclinical Service
Description

Veterinary radiosurgical operating theatre for interventional radiology procedures in preclinical animal models.

15Imaging Prototype Validation (Prototypage de nouvelles modalités d'imagerie)
CategoryInnovation Service
Description

Biomedical validation environment for academic and industrial imaging prototype development, including the Philips SPCCT v2, MAG4HEALTH OPM-MEG sensors, DAMAVAN Imaging 3D Compton camera, and ICONEUS functional ultrasound.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1CNRS (Centre National de la Recherche Scientifique)
Strategic tierCoreTypeOthers
Description

CERMEP is labeled by CNRS as UAR 2053 (Research Support Unit), receiving institutional recognition and support. CNRS is France's primary public research organization providing scientific oversight and funding.

cermep.fr
Strategic tierCoreTypeOthers
Description

CERMEP is labeled by INSERM as US65 (Service Unit), receiving institutional recognition and support. INSERM is France's national institute for medical research providing scientific oversight and funding.

Strategic tierCoreTypeOthers
Description

CERMEP is labeled by Lyon1 Université Claude Bernard as UAR 2053, receiving institutional support. The university provides academic affiliation and student/researcher access.

4Hospices Civils de Lyon
Strategic tierCoreTypeOthers
Description

CERMEP is supported by Hospices Civils de Lyon and located within the Groupement Hospitalier Est hospital complex, enabling access to clinical environments and patient populations.

cermep.fr
Strategic tierSignificantTypeStrategic or Co-development Partner
Description

Collaboration with Philips for the SPCCT (Spectral Photon Counting CT) scanner development and biomedical validation. The scanner has progressed to version 2 under this partnership.

Strategic tierSignificantTypeStrategic or Co-development Partner
Description

Collaboration with MAG4HEALTH for next-generation OPM (Optically Pumped Magnetometer) MEG sensors development and validation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration with DAMAVAN imaging for development and biomedical validation of 3D Compton camera prototype.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration with ICONEUS for functional Ultrasound (fUS) technology development and validation.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Siemens Healthineers is a major medical imaging equipment vendor (MRI, PET, CT, molecular imaging) that sells into research imaging platforms and competes with Philips in CERMEP's hardware base — relevant as ecosystem participant rather than direct peer.

TypeBroad incumbent
Description

Eurofins Discovery offers broad preclinical and clinical research services including imaging-related assays — comparable to CERMEP at the level of scientific services for pharma/biotech, but operating commercially across many more modalities.

TypeOthers
Description

Bruker BioSpin manufactures high-field MRI and PET systems used in preclinical imaging — comparable to CERMEP's 7T microMRI and PET instrumentation footprint, and an ecosystem participant as both vendor and adjacent research partner.

TypeBroad incumbent
Description

ICON is a large global CRO whose Medical Imaging services division competes with CERMEP for pharma clinical-trial imaging work — overlapping capability but at much greater scale and across multiple modalities and geographies.

TypeBroad incumbent
Description

Charles River provides preclinical imaging (microPET/CT, microMRI) and integrated drug discovery services — overlapping with CERMEP's preclinical animal imaging offering but as one part of a much broader discovery and development CRO portfolio.

6NeuroSpin (CEA)
TypeDirect peer
Description

CEA's NeuroSpin is a French public research platform specializing in high-field MRI (including 7T and 11.7T systems) for neuroscience research — the closest French analogue to CERMEP, with overlapping translational MRI capability and similar public research institution structure.

TypeDirect peer
Description

Invicro is a commercial CRO specializing in molecular imaging (PET and MRI) and central reading for clinical trials — directly comparable to CERMEP's clinical pharma contract work in neuroimaging and biomarker validation, though operating at commercial scale across multiple sites.

TypeOthers
Description

Philips is a CERMEP partner for the Spectral Photon Counting CT (SPCCT) and supplies clinical PET/CT and MRI systems used across imaging platforms — a key equipment vendor and co-development partner that determines part of CERMEP's technology roadmap.

9Martinos Center for Biomedical Imaging (MGH/Harvard)
TypeDirect peer
Description

The Martinos Center is a leading US academic multimodal imaging research center combining MRI, PET, MEG, and optical imaging for translational research — directly comparable to CERMEP's multimodal translational imaging mission and academic-research-platform structure.

TypeDirect peer
Description

Imagine is a French pediatric genetic disease research institute with embedded imaging capabilities — comparable as a public research institution with translational imaging, although more disease-focused than CERMEP's platform-level orientation.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CERMEP

Biomedical Imaging Research Servicescermep.fr

CERMEP is a French publicly funded multimodal biomedical imaging platform in Bron, serving academic and industrial researchers with PET, MRI, MEG, spectral CT, functional ultrasound, and on-site radiopharmaceutical production for preclinical and clinical studies.

What CERMEP does

CERMEP — Centre d'Étude et de Recherche Multimodal Et Pluridisciplinaire en imagerie du vivant — is a French publicly funded research support unit (Unité d'appui à la Recherche) labeled by CNRS as UAR 2053, by INSERM as US65, and supported by Lyon1 Université Claude Bernard and Hospices Civils de Lyon. Headquartered at the Groupement Hospitalier Est in Bron, France, the platform provides in vivo biomedical imaging services spanning preclinical (small and medium animal) and clinical research, anchored by a multimodal equipment fleet that includes PET (with combined PET/MRI and PET/CT scanners), MRI at 1.5T, 3T, and 7T (including a 7T microMRI), spectral photon-counting CT (SPCCT), magnetoencephalography (MEG) using OPM sensors, and functional ultrasound (fUS). The platform supplements imaging with on-site radiopharmaceutical production via cyclotron and radiochemistry laboratories, pharmacokinetic modeling, image data analysis, and a preclinical animal facility with a radiosurgical block.

The business model is publicly funded rather than commercial: revenue flows from institutional grants and contributions by CNRS, INSERM, Lyon1, and Hospices Civils de Lyon, supplemented by collaborative research agreements with pharmaceutical and biotechnology industry partners. Customer segments split between academic biomedical researchers (primary, preclinical and translational), clinical research teams (RIPH 1 & 2 interventional studies, GCP-trained personnel, ISO 9001-certified processes since 2007), and industry partners (drug development imaging, pharmacokinetic characterization, biomarker validation, clinical trial support). Go-to-market is enterprise field sales in nature — protocols are designed with researchers and validated by the platform's Comex committee before any imaging study is initiated.

CERMEP additionally functions as a biomedical validation hub for next-generation imaging prototypes, with active co-development engagements with Philips (SPCCT v2), MAG4HEALTH (OPM-MEG sensors), DAMAVAN Imaging (3D Compton camera prototype), and ICONEUS (functional ultrasound). The platform's competitive position rests on the unique convergence of regulated clinical-grade quality management (ISO 9001 since 2007), capital-intensive multimodal hardware unavailable at most European research sites, and structural embedding within one of Europe's densest hospital-university complexes.

CERMEP firmographics

Firmographics
Name
CERMEP
Legal name
CERMEP - Imagerie du Vivant (Centre d'Etude et de Recherche Multimodal Et Pluridisciplinaire en imagerie du vivant)
Website
https://cermep.fr
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
CERMEP is a French publicly funded multimodal biomedical imaging platform in Bron, serving academic and industrial researchers with PET, MRI, MEG, spectral CT, functional ultrasound, and on-site radiopharmaceutical production for preclinical and clinical studies.
Ownership category
akta.pro rank

CERMEP industry classification

Industry
Product category
Biomedical Imaging Research Services
NAICS
Diagnostic Imaging Centers (621512), Other Scientific and Technical Consulting Services (54169), Veterinary Services (54194), Professional, Scientific, and Technical Services (54)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAGAAAJ
Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG)
SECONDARYHLAFAKAK
Neurodiagnostic Centers (EEG/EMG/NCS)

Keywords

  • Biomedical imaging research
  • Multimodal imaging platform
  • PET radiopharmaceutical production
  • Preclinical clinical imaging
  • Translational imaging services

Where CERMEP is headquartered

Location

Headquarters

HQ city
Bron
HQ country
France
HQ region
Europe

Offices4 records

Markets served

CERMEP business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Infrastructure, Personnel, Technology or R&D, Operations

Revenue model

  1. Research Services (Public Funding): CERMEP operates as a CNRS/INSERM research support unit (UAR 2053 / US65) funded by French public research institutions including CNRS, INSERM, Lyon1 Université Claude Bernard, and Hospices Civils de Lyon. Revenue derived from public research grants and institutional support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

CERMEP product offering

Product offering

Core offering

CERMEP is a multimodal biomedical imaging platform providing preclinical and clinical in vivo imaging services. It combines PET, MRI (1.5T, 3T, 7T, micro-IRM), combined PET-MRI, PET/CT, spectral photon-counting CT, MEG, and functional ultrasound with on-site radiopharmaceutical production via cyclotron, pharmacokinetic modeling, and image data analysis. Services are delivered to academic researchers and industrial partners through validated protocols executed by specialized imaging teams.

Product overview

CERMEP is a unified multimodal biomedical imaging platform combining preclinical and clinical imaging services within a single hospital-university site. Its core offering integrates a suite of imaging modalities — PET molecular imaging, MRI (1.5T, 3T, 7T, and micro-IRM 7T), combined PET-MRI, PET/CT, spectral photon-counting CT (SPCCT), MEG, and functional ultrasound (fUS) — with on-site radiopharmaceutical production via cyclotron, pharmacokinetic modeling, and advanced image data analysis services. The platform also provides preclinical animal housing and a radiosurgical block, and serves as a biomedical validation hub for academic and industrial imaging prototype development. Services are delivered through specialized technical teams (MER, engineers, technicians) and support the full research pipeline from protocol design through data acquisition, analysis, and methodological innovation.

Differentiator

Problem solved

Functional benefit

Products and services

  • PET Molecular Imaging (Imagerie moléculaire TEP) Positron emission tomography for functional imaging of radiopharmaceutical biodistribution as markers of biological processes. Available for preclinical and clinical research.
  • MRI Imaging (Imagerie par Résonance Magnétique) Magnetic resonance imaging at 1.5T, 3T, and 7T field strengths, covering both preclinical (micro-IRM 7T) and clinical anatomical and functional imaging.
  • Combined PET-MRI (TEP-IRM combinée) Combined PET-MRI scanner enabling simultaneous acquisition of molecular (PET) and anatomical/functional (MRI) data in a single imaging session for integrated research.
  • PET/CT Imaging (TEP/CT) Combined PET/CT scanner merging molecular PET data with anatomical CT data for clinical and preclinical imaging research.
  • Spectral Photon-Counting CT (SPCCT) Spectral CT scanner using photon-counting detector technology for anatomical and functional multispectral imaging.
  • Magnetoencephalography (MEG) Functional imaging of cerebral magnetic field changes, including next-generation optically pumped magnetometer (OPM) sensors.
  • Functional Ultrasound (fUS) High-resolution functional ultrasound imaging for preclinical studies utilizing ICONEUS technology.
  • MicroPET/CT (MicroTEP/CT) Preclinical micro-PET/CT system for small animal (rodent) imaging combining molecular and anatomical imaging.
  • MicroMRI 7T (MicroIRM 7T) 7 Tesla micro-MRI scanner for high-resolution preclinical anatomical and functional imaging of small animals.
  • PET Radiopharmaceutical Production (Production de radiopharmaceutiques TEP) On-site production of PET radiopharmaceuticals using the cyclotron and radiosynthesis laboratories, including development of new radiotracers and labeling pathways.
  • Pharmacokinetic Modeling (Modélisation pharmacocinétique) Pharmacokinetic modeling services using compartmental modeling with invasive input function and reference region methods, spanning preclinical animal studies through first-in-human clinical studies.
  • Image Data Analysis (Analyse de données d'imagerie) Image data analysis services covering preprocessing, processing, and analysis of PET-MRI combined and MEG data, including custom tool and script development.
  • Animal Facility and Preclinical Experimentation (Animalerie / Expérimentation animale) Preclinical animal experimentation and housing facilities for imaging studies across species including rodents, rabbits, pigs, and non-human primates.
  • Radiosurgical Operating Block (Bloc radiochirurgical) Veterinary radiosurgical operating theatre for interventional radiology procedures in preclinical animal models.
  • Imaging Prototype Validation (Prototypage de nouvelles modalités d'imagerie) Biomedical validation environment for academic and industrial imaging prototype development, including the Philips SPCCT v2, MAG4HEALTH OPM-MEG sensors, DAMAVAN Imaging 3D Compton camera, and ICONEUS functional ultrasound.

Companies that use CERMEP

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

CERMEP technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

CERMEP partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, significant and minor.

  • CNRS (Centre National de la Recherche Scientifique)coreOthersCERMEP is labeled by CNRS as UAR 2053 (Research Support Unit), receiving institutional recognition and support. CNRS is France's primary public research organization providing scientific oversight and funding.
  • INSERM (Institut National de la Santé et de la Recherche Médicale)coreOthersCERMEP is labeled by INSERM as US65 (Service Unit), receiving institutional recognition and support. INSERM is France's national institute for medical research providing scientific oversight and funding.
  • Lyon1 Université Claude BernardcoreOthersCERMEP is labeled by Lyon1 Université Claude Bernard as UAR 2053, receiving institutional support. The university provides academic affiliation and student/researcher access.
  • Hospices Civils de LyoncoreOthersCERMEP is supported by Hospices Civils de Lyon and located within the Groupement Hospitalier Est hospital complex, enabling access to clinical environments and patient populations.
  • Philips (Spectral Photon Counting CT)significantStrategic or Co-development PartnerCollaboration with Philips for the SPCCT (Spectral Photon Counting CT) scanner development and biomedical validation. The scanner has progressed to version 2 under this partnership.
  • MAG4HEALTHsignificantStrategic or Co-development PartnerCollaboration with MAG4HEALTH for next-generation OPM (Optically Pumped Magnetometer) MEG sensors development and validation.
  • DAMAVAN imagingminorStrategic or Co-development PartnerCollaboration with DAMAVAN imaging for development and biomedical validation of 3D Compton camera prototype.
  • ICONEUSminorStrategic or Co-development PartnerCollaboration with ICONEUS for functional Ultrasound (fUS) technology development and validation.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

CERMEP competitors and assessment

Company assessment

Others

  • Siemens Healthineers: Siemens Healthineers is a major medical imaging equipment vendor (MRI, PET, CT, molecular imaging) that sells into research imaging platforms and competes with Philips in CERMEP's hardware base — relevant as ecosystem participant rather than direct peer.
  • Bruker BioSpin: Bruker BioSpin manufactures high-field MRI and PET systems used in preclinical imaging — comparable to CERMEP's 7T microMRI and PET instrumentation footprint, and an ecosystem participant as both vendor and adjacent research partner.
  • Philips (Image Guided Therapy / Radiology): Philips is a CERMEP partner for the Spectral Photon Counting CT (SPCCT) and supplies clinical PET/CT and MRI systems used across imaging platforms — a key equipment vendor and co-development partner that determines part of CERMEP's technology roadmap.

Broad incumbents

  • Eurofins Discovery: Eurofins Discovery offers broad preclinical and clinical research services including imaging-related assays — comparable to CERMEP at the level of scientific services for pharma/biotech, but operating commercially across many more modalities.
  • ICON plc: ICON is a large global CRO whose Medical Imaging services division competes with CERMEP for pharma clinical-trial imaging work — overlapping capability but at much greater scale and across multiple modalities and geographies.
  • Charles River Laboratories: Charles River provides preclinical imaging (microPET/CT, microMRI) and integrated drug discovery services — overlapping with CERMEP's preclinical animal imaging offering but as one part of a much broader discovery and development CRO portfolio.

Direct peers

  • NeuroSpin (CEA): CEA's NeuroSpin is a French public research platform specializing in high-field MRI (including 7T and 11.7T systems) for neuroscience research — the closest French analogue to CERMEP, with overlapping translational MRI capability and similar public research institution structure.
  • Invicro (a Calyx company): Invicro is a commercial CRO specializing in molecular imaging (PET and MRI) and central reading for clinical trials — directly comparable to CERMEP's clinical pharma contract work in neuroimaging and biomarker validation, though operating at commercial scale across multiple sites.
  • Martinos Center for Biomedical Imaging (MGH/Harvard): The Martinos Center is a leading US academic multimodal imaging research center combining MRI, PET, MEG, and optical imaging for translational research — directly comparable to CERMEP's multimodal translational imaging mission and academic-research-platform structure.
  • Imagine Institute (Institut Imagine): Imagine is a French pediatric genetic disease research institute with embedded imaging capabilities — comparable as a public research institution with translational imaging, although more disease-focused than CERMEP's platform-level orientation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

CERMEP social profiles

Digital presence

CERMEP compliance and trust

Trust signal

Compliance1 record

CERMEP financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CERMEP leadership team

Management profile

Number of profiles

Profiles1 record

CERMEP funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CERMEP M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CERMEP

What does CERMEP do?

CERMEP is a multimodal biomedical imaging platform providing preclinical and clinical in vivo imaging services. It combines PET, MRI (1.5T, 3T, 7T, micro-IRM), combined PET-MRI, PET/CT, spectral photon-counting CT, MEG, and functional ultrasound with on-site radiopharmaceutical production via cyclotron, pharmacokinetic modeling, and image data analysis. Services are delivered to academic researchers and industrial partners through validated protocols executed by specialized imaging teams.

Is CERMEP a public or private company?

CERMEP is a private company. It is classified as state government owned and is currently operating.

When was CERMEP founded?

CERMEP was founded in 2007. It employs 11 to 50 people.

Where is CERMEP based?

CERMEP is headquartered in Bron, France, in the Europe region.

How does CERMEP make money?

One revenue line is on record: research Services (Public Funding).

Who are CERMEP's main competitors?

Others on record are Siemens Healthineers, Bruker BioSpin and Philips (Image Guided Therapy / Radiology). Broad incumbents are Eurofins Discovery, ICON plc and Charles River Laboratories. Direct peers are NeuroSpin (CEA), Invicro (a Calyx company), Martinos Center for Biomedical Imaging (MGH/Harvard) and Imagine Institute (Institut Imagine).

Does CERMEP have an API?

No public API is recorded for CERMEP.

What industry is CERMEP in?

CERMEP's product category is Biomedical Imaging Research Services. Its primary akta.pro industry code is HLAGAAAJ, Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG), with a secondary code of HLAFAKAK, Neurodiagnostic Centers (EEG/EMG/NCS). Its NAICS code is 621512 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales